PSY396H1 Study Guide - Winter 2019, Comprehensive Midterm Notes - Meds, Placebo, Ziprasidone
Document Summary
K+ open (counterbalancing na+), na+ closing: 5. Adhd rating scale compared to 8% for placebo: conclusion: guanfacine = safe & e ective treatment for children w/ tic disorders & 4=no change, 7=deterioration: parent conners questionnaire, hyperactivity index, yale global tic severity scale: clinical interview designed to measure tic severity, three summary scores: > gradual transition to study meds: hypothesis: signi cant differences in overall effectiveness between 5 drugs in treating. & atypical drugs: no signi cant differences among drugs in time until discontinuation of treatment owing to intolerable side effects, olanzapine associated w/ greater weight gain, etc. > changes that may lead to development of the metabolic syndrome: the nimh-catie schizophrenia study: what did we learn, when catie study was designed, prevailing opinion = 2nd-generation vastly superior to. West lj, pierce cm & thomas wd (1962) lysergic acid diethylamide: its effects on a.
